Virtus Biotech Clinical Trials Etf (BBC) is an ETF managed by Independent / Boutique. Its largest position is DREYFUS GOVERNMENT CASH MANAGEMENT (MISXX), representing 2.28% of fund assets.
Virtus Biotech Clinical Trials Etf Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BBC
- Type:
- ETF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 22, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
DREYFUS GOVERNMENT CASH MANAGEMENT
|
2.28% | $852,187.85 | 852,188 |
|
-
Erasca, Inc.
|
2.19% | $816,514.20 | 76,668 |
|
-
Enliven Therapeutics, Inc.
|
1.81% | $674,935.10 | 16,370 |
|
-
Tango Therapeutics, Inc.
|
1.71% | $638,179.16 | 29,518 |
|
-
Oruka Therapeutics, Inc.
|
1.68% | $625,472.63 | 9,143 |
|
-
Spyre Therapeutics, Inc.
|
1.64% | $611,085.60 | 8,208 |
|
-
ALUMIS INC.
|
1.59% | $593,053.80 | 24,020 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
1.54% | $575,177.80 | 6,551 |
|
-
Kodiak Sciences Inc.
|
1.35% | $503,976.68 | 11,591 |
|
-
Revolution Medicines, Inc.
|
1.35% | $503,843.52 | 3,496 |
|
-
Corvus Pharmaceuticals, Inc.
|
1.34% | $500,905.44 | 32,976 |
|
-
Rezolute, Inc.
|
1.31% | $490,681.60 | 153,338 |
|
-
Definium Therapeutics, Inc.
|
1.29% | $481,206.84 | 21,993 |
|
-
CG Oncology, Inc.
|
1.21% | $449,894.34 | 6,741 |
|
-
Jade Biosciences, Inc.
|
1.20% | $449,570.00 | 18,425 |
|
-
Inhibrx Biosciences, Inc.
|
1.20% | $447,971.07 | 3,467 |
|
-
Relay Therapeutics, Inc.
|
1.19% | $445,448.16 | 34,371 |
|
-
GH Research PLC
|
1.16% | $434,722.75 | 21,175 |
|
-
NEKTAR THERAPEUTICS
|
1.15% | $429,026.80 | 5,045 |
|
-
Tyra Biosciences, Inc.
|
1.14% | $423,811.00 | 12,196 |
|
-
Vir Biotechnology, Inc.
|
1.13% | $421,430.04 | 41,256 |
|
-
Intellia Therapeutics, Inc.
|
1.10% | $412,474.52 | 30,599 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
1.10% | $410,401.62 | 10,411 |
|
-
ANAPTYSBIO, INC
|
1.08% | $403,516.47 | 6,139 |
|
-
OMEROS CORP
|
1.06% | $397,003.20 | 27,192 |
|
-
Tectonic Therapeutic, Inc.
|
1.05% | $390,629.02 | 13,966 |
|
-
Allogene Therapeutics, Inc.
|
1.04% | $389,338.44 | 182,788 |
|
-
COMPASS Pathways plc
|
0.99% | $371,007.00 | 40,950 |
|
-
Edgewise Therapeutics, Inc.
|
0.97% | $361,767.60 | 11,685 |
|
-
PALVELLA THERAPEUTICS, INC.
|
0.96% | $359,039.36 | 2,798 |
|
-
CAPRICOR THERAPEUTICS, INC.
|
0.95% | $356,149.48 | 10,606 |
|
-
Vaxcyte, Inc.
|
0.95% | $354,945.24 | 6,201 |
|
-
Pharvaris N.V.
|
0.95% | $354,258.24 | 11,424 |
|
-
ArriVent BioPharma, Inc.
|
0.94% | $351,317.00 | 11,300 |
|
-
Xenon Pharmaceuticals Inc.
|
0.94% | $351,034.56 | 6,264 |
|
-
Neurogene Inc.
|
0.92% | $344,205.37 | 13,193 |
|
-
Summit Therapeutics Inc.
|
0.90% | $337,093.68 | 15,708 |
|
-
Amylyx Pharmaceuticals, Inc.
|
0.90% | $337,088.00 | 21,068 |
|
-
Celldex Therapeutics, Inc.
|
0.88% | $329,852.16 | 10,032 |
|
-
Praxis Precision Medicines, Inc.
|
0.88% | $327,119.58 | 1,026 |
|
-
Arcus Biosciences, Inc.
|
0.88% | $326,884.50 | 12,819 |
|
-
Annexon, Inc.
|
0.87% | $325,990.45 | 55,535 |
|
-
TERNS PHARMACEUTICALS INC
|
0.87% | $324,566.76 | 6,132 |
|
-
Liquidia Corp
|
0.87% | $324,188.28 | 8,268 |
|
-
Monte Rosa Therapeutics, Inc.
|
0.87% | $324,056.30 | 16,922 |
|
-
Immunome Inc.
|
0.87% | $323,499.88 | 14,102 |
|
-
Bicara Therapeutics Inc.
|
0.86% | $322,275.72 | 14,934 |
|
-
Celcuity Inc.
|
0.85% | $318,058.35 | 2,621 |
|
-
IRONWOOD PHARMACEUTICALS INC
|
0.85% | $318,025.13 | 77,097 |
|
-
AbCellera Biologics Inc.
|
0.85% | $316,416.75 | 76,245 |
Advertisement (320x50)